Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422160 · ClinicalTrials.gov registry record
Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 28
- Enrollment target
NCT02422160: Completed study, sponsored by Stanford University.
NCT02422160 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422160 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.
Interventions
- OTHER No interventions are planned
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-04 |
| Est. Completion | 2021-12 |
What the finished NCT02422160 record still lists
NCT02422160 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No interventions are planned is the first listed.
NCT02422160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02422160 about?
NCT02422160 is a clinical study titled "Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration". The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practi...
What is the current status of trial NCT02422160?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2015-04. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02422160?
The interventions under investigation include: No interventions are planned (OTHER).
Who is sponsoring clinical trial NCT02422160?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia